A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis

Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), David C. Johnson(Institute of Cancer Research), Ditte Starberg Jespersen(Aalborg University Hospital), Rasmus Froberg Brøndum(Aarhus University), Karen Dybkær(Aalborg University Hospital), Charles Vesteghem(Aalborg University Hospital), Rajen D. Shah(Chr. Hansen (Denmark)), Martín Pérez‐Andrés(Universidad de Salamanca), Faith E. Davies(NYU Langone Health), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Mehmet Samur(Dana-Farber Cancer Institute), Anna A. Schönherz(Aalborg University Hospital), Brian A. Walker(University of Miami), Nikhil C. Munshi(Dana-Farber Cancer Institute), Mads Sønderkær(Aalborg University), Hartmut Goldschmidt(Heidelberg University), Alexander Schmitz(Chr. Hansen (Denmark)), Uta Bertsch(Heidelberg University), Caroline Holm Nørgaard(Nordsjællands Hospital), Hans Erik Johnsen(Herlev Hospital), Charlotte Pawlyn(Royal Marsden NHS Foundation Trust), Martin Kaiser(Royal Marsden NHS Foundation Trust), Hanne Due(Aalborg University Hospital), Annemiek Broyl(Erasmus MC), Preben Johansen(Chr. Hansen (Denmark)), Alberto Órfão(Universidad de Salamanca), Mark van Duin(Erasmus MC Cancer Institute), Gareth J. Morgan(Hywel Dda University Health Board), Pieter Sonneveld(Erasmus MC Cancer Institute), Martin Agge Nørgaard, Richard J. Samworth(University of Cambridge)
Blood Advances
September 25, 2018
Cited by 6


Related Papers